Skip to content

Shiryn D. Sukhram

2 papers in the library · 26 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Ketamine in Diabetes Care: Metabolic Insights and Clinical Applications.

Pharmaceutics January 8, 2026 Shiryn D. Sukhram, Majandra Sanchez, Ayotunde Anidugbe et al.

Background: Depression and diabetic neuropathy (DN) commonly complicate diabetes and impair glycemic control and quality of life. Ketamine and its S-enantiomer, esketamine, provide rapid antidepressant and analgesic effects, yet diabetes-related pathophysiology and co-therapies may modify exposure, response, and safety. Methods: We conducted a scoping review following PRISMA-ScR....

Antidepressant Effect of Ketamine on Inflammation‐Mediated Cytokine Dysregulation in Adults with Treatment‐Resistant Depression: Rapid Systematic Review

Oxidative Medicine and Cellular Longevity 2022 Shiryn D. Sukhram, Grozdena Yilmaz, Jianying Gu 26 citations

Background . Major depressive disorder (MDD) and treatment‐resistant depression (TRD) represent a global source of societal and health burden. To advise proper management of inflammation‐related depression among TRD patients, it is important to identify therapeutic clinical treatments. A key factor is related to proinflammatory cytokines such as interleukin‐ (IL‐) 1 β , IL‐6, and tumor necrosis...